PortViewPortView
Outlook Therapeutics logo

Outlook Therapeutics (OTLKW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.03-1.96%
1-year price historyRange $0.03 – $0.22
52-week range$0.03
$0.01$0.04

What Outlook Therapeutics does

Outlook Therapeutics, Inc. - Se (NASDAQ: OTLKW) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$0
P/E (TTM)
0.00
Beta
0.00
Dividend yield
0.00%
Revenue / share
$-0.05
50-day avg
$0.00
200-day avg
$0.00
52-week high
$0.04
52-week low
$0.01

ETFs linked to OTLKW

Broad-market and Healthcare sector ETFs an investor holding Outlook Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OTLKW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OTLKW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Outlook Therapeutics?
Outlook Therapeutics trades under the ticker OTLKW on NASDAQ.
Which exchange is OTLKW listed on?
OTLKW is listed on NASDAQ.
What sector does Outlook Therapeutics operate in?
Outlook Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OTLKW in a portfolio?
PortView shows OTLKW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.